S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

NASDAQ:CVET - Covetrus Stock Price, Forecast & News

$11.99
-0.54 (-4.31 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$11.94
Now: $11.99
$12.62
50-Day Range
$12.30
MA: $13.52
$15.23
52-Week Range
$8.16
Now: $11.99
$39.98
Volume22,606 shs
Average Volume1.25 million shs
Market Capitalization$1.34 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:CVET
CUSIPN/A
CIKN/A
Phone888-280-2221

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.78 billion

Profitability

Net Income$100.86 million

Miscellaneous

Employees5,000
Market Cap$1.34 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive CVET News and Ratings via Email

Sign-up to receive the latest news and ratings for CVET and its competitors with MarketBeat's FREE daily newsletter.


Covetrus (NASDAQ:CVET) Frequently Asked Questions

What is Covetrus' stock symbol?

Covetrus trades on the NASDAQ under the ticker symbol "CVET."

How were Covetrus' earnings last quarter?

Covetrus Inc (NASDAQ:CVET) released its quarterly earnings data on Tuesday, November, 12th. The company reported $0.17 EPS for the quarter, beating the Zacks' consensus estimate of $0.08 by $0.09. The business earned $1.02 billion during the quarter, compared to analysts' expectations of $963.69 million. Covetrus had a negative net margin of 23.15% and a positive return on equity of 4.26%. The company's quarterly revenue was up 10.3% on a year-over-year basis. View Covetrus' Earnings History.

When is Covetrus' next earnings date?

Covetrus is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Covetrus.

What price target have analysts set for CVET?

7 Wall Street analysts have issued 1-year target prices for Covetrus' stock. Their forecasts range from $11.00 to $21.00. On average, they anticipate Covetrus' stock price to reach $15.25 in the next year. This suggests a possible upside of 27.2% from the stock's current price. View Analyst Price Targets for Covetrus.

What is the consensus analysts' recommendation for Covetrus?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Covetrus in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Covetrus.

Has Covetrus been receiving favorable news coverage?

Media stories about CVET stock have trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Covetrus earned a news impact score of -3.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Covetrus.

Who are some of Covetrus' key competitors?

What other stocks do shareholders of Covetrus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Covetrus investors own include Uber Technologies (UBER), Evolent Health (EVH), Century Aluminum (CENX), IDEXX Laboratories (IDXX), PetIQ (PETQ), RealReal (REAL), SmileDirectClub (SDC), SVMK (SVMK), Canopy Growth (CGC) and Chewy (CHWY).

Who are Covetrus' key executives?

Covetrus' management team includes the folowing people:
  • Benjamin J. Shaw, President, Chief Executive Officer & Director
  • Christine Tomlinson Komola, Chief Financial Officer & Executive Vice President
  • Matthew Leonard, Executive VP & President-North America
  • Jim Young, Chief Human Resources Officer & Senior VP
  • Erin Powers Brennan, Secretary, Senior Vice President & General Counsel

Who are Covetrus' major shareholders?

Covetrus' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2.79%), State Street Corp (2.41%), First Trust Advisors LP (2.36%), Kovitz Investment Group Partners LLC (2.11%), Geode Capital Management LLC (1.02%) and Bank of New York Mellon Corp (0.96%). Company insiders that own Covetrus stock include Benjamin Shaw, Betsy S Atkins, David Christopher Dollar, Erin Powers Brennan and Timothy Ludlow. View Institutional Ownership Trends for Covetrus.

Which institutional investors are selling Covetrus stock?

CVET stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bank of America Corp DE, Credit Suisse AG, American International Group Inc., Gabelli Funds LLC, Man Group plc, Kovitz Investment Group Partners LLC and State Street Corp. Company insiders that have sold Covetrus company stock in the last year include Betsy S Atkins, David Christopher Dollar and Timothy Ludlow. View Insider Buying and Selling for Covetrus.

Which institutional investors are buying Covetrus stock?

CVET stock was acquired by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Prudential Financial Inc., Principal Financial Group Inc., BNP PARIBAS ASSET MANAGEMENT Holding S.A., Palisade Capital Management LLC NJ, Russell Investments Group Ltd., Public Sector Pension Investment Board and Madison Asset Management LLC. Company insiders that have bought Covetrus stock in the last two years include Benjamin Shaw and Erin Powers Brennan. View Insider Buying and Selling for Covetrus.

How do I buy shares of Covetrus?

Shares of CVET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Covetrus' stock price today?

One share of CVET stock can currently be purchased for approximately $11.99.

How big of a company is Covetrus?

Covetrus has a market capitalization of $1.34 billion and generates $3.78 billion in revenue each year. Covetrus employs 5,000 workers across the globe.View Additional Information About Covetrus.

What is Covetrus' official website?

The official website for Covetrus is http://www.henryscheinvet.com/.

How can I contact Covetrus?

Covetrus' mailing address is 7 CUSTOM HOUSE STREET, PORTLAND ME, 04101. The company can be reached via phone at 888-280-2221 or via email at [email protected]


MarketBeat Community Rating for Covetrus (NASDAQ CVET)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  84 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  204
MarketBeat's community ratings are surveys of what our community members think about Covetrus and other stocks. Vote "Outperform" if you believe CVET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel